Literature DB >> 28203692

Neuropsychological profiles of vascular disease and risk of dementia: implications for defining vascular cognitive impairment no dementia (VCI-ND).

Blossom Christa Maree Stephan1, Thais Minett2, Graciela Muniz-Terrera3, Stephanie L Harrison1, Fiona E Matthews4, Carol Brayne2.   

Abstract

Background: vascular cognitive impairment no dementia (VCI-ND) defines a preclinical phase of cognitive decline associated with vascular disorders. The neuropsychological profile of VCI-ND may vary according to different vascular conditions. Objective: to determine the neuropsychological profile of individuals with no dementia and vascular disorders, including hypertension, peripheral vascular disease (PVD), coronary heart disease (CHD), diabetes and stroke. Risk of 2-year incident dementia in individuals with disease and cognitive impairment was also tested.
Methods: participants were from the Cognitive Function and Ageing Study. At baseline, 13,004 individuals aged ≥65 years were enrolled into the study. Individuals were grouped by baseline disorder status (present, absent) for each condition. Cognitive performance was assessed using the Mini Mental State Examination (MMSE) and the Cambridge Cognitive Examination (CAMCOG). Dementia was assessed at 2 years.
Results: in the cross-sectional analysis, hypertension, PVD and CHD were not associated with cognitive impairment. Stroke was associated with impaired global (MMSE) and CAMCOG sub-scale (including memory and non-memory) scores. Diabetes was associated with impairments in global cognitive function (MMSE) and abstract thinking. In the longitudinal analysis, cognitive impairments were associated with incident dementia in all groups.
Conclusion: the neuropsychological profile in individuals with vascular disorders depends on the specific condition investigated. In all conditions cognitive impairment is a risk factor for dementia. A better understanding of which cognitive domains are affected in different disease groups could help improve operationalisation of the neuropsychological criteria for VCI-ND and could also aid with the development of dementia risk prediction models in persons with vascular disease.
© The Author 2017. Published by Oxford University Press on behalf of the British Geriatrics Society.

Entities:  

Keywords:  cognition; dementia risk; epidemiology; older people; vascular cognitive impairment no dementia; vascular disease

Mesh:

Year:  2017        PMID: 28203692      PMCID: PMC5474097          DOI: 10.1093/ageing/afx016

Source DB:  PubMed          Journal:  Age Ageing        ISSN: 0002-0729            Impact factor:   10.668


  30 in total

Review 1.  Predictors and assessment of cognitive dysfunction resulting from ischaemic stroke.

Authors:  Rebecca F Gottesman; Argye E Hillis
Journal:  Lancet Neurol       Date:  2010-09       Impact factor: 44.182

2.  A semi-structured clinical interview for the assessment of diagnosis and mental state in the elderly: the Geriatric Mental State Schedule. I. Development and reliability.

Authors:  J R Copeland; M J Kelleher; J M Kellett; A J Gourlay; B J Gurland; J L Fleiss; L Sharpe
Journal:  Psychol Med       Date:  1976-08       Impact factor: 7.723

3.  A computerized psychiatric diagnostic system and case nomenclature for elderly subjects: GMS and AGECAT.

Authors:  J R Copeland; M E Dewey; H M Griffiths-Jones
Journal:  Psychol Med       Date:  1986-02       Impact factor: 7.723

4.  Lower cognitive function in the presence of obesity and hypertension: the Framingham heart study.

Authors:  M F Elias; P K Elias; L M Sullivan; P A Wolf; R B D'Agostino
Journal:  Int J Obes Relat Metab Disord       Date:  2003-02

5.  Impact of cardiovascular risk factors on cognitive function: the Tromsø study.

Authors:  K A Arntzen; H Schirmer; T Wilsgaard; E B Mathiesen
Journal:  Eur J Neurol       Date:  2010-12-08       Impact factor: 6.089

6.  Midlife hypertension and 20-year cognitive change: the atherosclerosis risk in communities neurocognitive study.

Authors:  Rebecca F Gottesman; Andrea L C Schneider; Marilyn Albert; Alvaro Alonso; Karen Bandeen-Roche; Laura Coker; Josef Coresh; David Knopman; Melinda C Power; Andreea Rawlings; A Richey Sharrett; Lisa M Wruck; Thomas H Mosley
Journal:  JAMA Neurol       Date:  2014-10       Impact factor: 18.302

7.  Progressive cognitive impairment after stroke.

Authors:  James F Toole; Rafeeque Bhadelia; Jeff D Williamson; Roland Veltkamp
Journal:  J Stroke Cerebrovasc Dis       Date:  2004 May-Jun       Impact factor: 2.136

8.  National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards.

Authors:  Vladimir Hachinski; Costantino Iadecola; Ron C Petersen; Monique M Breteler; David L Nyenhuis; Sandra E Black; William J Powers; Charles DeCarli; Jose G Merino; Raj N Kalaria; Harry V Vinters; David M Holtzman; Gary A Rosenberg; Anders Wallin; Martin Dichgans; John R Marler; Gabrielle G Leblanc
Journal:  Stroke       Date:  2006-08-17       Impact factor: 7.914

9.  Hypertension and cognitive decline: impact on executive function.

Authors:  Augusto Vicario; Carlos D Martinez; Dolores Baretto; Alejandra Diaz Casale; Liliana Nicolosi
Journal:  J Clin Hypertens (Greenwich)       Date:  2005-10       Impact factor: 3.738

10.  "Concordance between comorbidity data from patient self-report interviews and medical record documentation".

Authors:  William Corser; Alla Sikorskii; Ade Olomu; Manfred Stommel; Camille Proden; Margaret Holmes-Rovner
Journal:  BMC Health Serv Res       Date:  2008-04-16       Impact factor: 2.655

View more
  3 in total

1.  The Value of Brain Structural Magnetic Resonance Imaging Combined with APOE--ε4 Genotype in Early Diagnosis and Disease Progression of Senile Vascular Cognitive Impairment No Dementia.

Authors:  Weina Zhao; Changhao Yin; Fengbo Yu; Lifei Wan; Siyao Che; Lili Cui
Journal:  Contrast Media Mol Imaging       Date:  2022-03-05       Impact factor: 3.009

2.  Using the Oxford Cognitive Screen to Detect Cognitive Impairment in Stroke Patients: A Comparison with the Mini-Mental State Examination.

Authors:  Mauro Mancuso; Nele Demeyere; Laura Abbruzzese; Alessio Damora; Valentina Varalta; Fabio Pirrotta; Gabriella Antonucci; Alessandro Matano; Marina Caputo; Maria Giovanna Caruso; Giovanna Teresa Pontiggia; Michela Coccia; Irene Ciancarelli; Pierluigi Zoccolotti
Journal:  Front Neurol       Date:  2018-02-28       Impact factor: 4.003

3.  The Relationship of Coronary Artery Calcium and Clinical Coronary Artery Disease with Cognitive Function: A Systematic Review and Meta-Analysis.

Authors:  Congying Xia; Marleen Vonder; Grigory Sidorenkov; Matthijs Oudkerk; Jan Cees de Groot; Pim van der Harst; Geertruida H de Bock; Peter Paul De Deyn; Rozemarijn Vliegenthart
Journal:  J Atheroscler Thromb       Date:  2020-02-15       Impact factor: 4.928

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.